Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics

Benzer Materyaller

• Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics
  Yazar:: Renee Brady-Nicholls, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-09-01)
• Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots
  Yazar:: Per-Anders Abrahamsson
  Baskı/Yayın Bilgisi: (2017-10-01)
• Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: Where is the evidence?
  Yazar:: T J Nirmal, ve diğerleri
  Baskı/Yayın Bilgisi: (2010-01-01)
• Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy.
  Yazar:: Yoshito Hirata, ve diğerleri
  Baskı/Yayın Bilgisi: (2015-01-01)
• Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix
  Yazar:: Patrick Campbell, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-11-01)